Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Net Margin % : -2,729,500.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Chongqing Genrix Biopharmaceutical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Chongqing Genrix Biopharmaceutical Co's Net Income for the three months ended in Mar. 2024 was ¥-163.77 Mil. Chongqing Genrix Biopharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥0.01 Mil. Therefore, Chongqing Genrix Biopharmaceutical Co's net margin for the quarter that ended in Mar. 2024 was -2,729,500.00%.

The historical rank and industry rank for Chongqing Genrix Biopharmaceutical Co's Net Margin % or its related term are showing as below:

SHSE:688443' s Net Margin % Range Over the Past 10 Years
Min: -509612.9 Med: -66115.43 Max: -821.98
Current: -68408.24

SHSE:688443's Net Margin % is ranked worse than
97.15% of 1018 companies
in the Biotechnology industry
Industry Median: -148.36 vs SHSE:688443: -68408.24

Chongqing Genrix Biopharmaceutical Co Net Margin % Historical Data

The historical data trend for Chongqing Genrix Biopharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Genrix Biopharmaceutical Co Net Margin % Chart

Chongqing Genrix Biopharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

-509,612.90

-34,247.79

-821.98

-121,340.21

-66,115.43

Chongqing Genrix Biopharmaceutical Co Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial								-200,969.00	-567,230.30	-3,001,466.67	-21,742.16	-2,729,500.00

Competitive Comparison of Chongqing Genrix Biopharmaceutical Co's Net Margin %

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's Net Margin % falls into.

Chongqing Genrix Biopharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Chongqing Genrix Biopharmaceutical Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-801.319	/	1.212
	=	-66,115.43 %

Chongqing Genrix Biopharmaceutical Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-163.77	/	0.006
	=	-2,729,500.00 %

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Chongqing Genrix Biopharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Chongqing Genrix Biopharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chongqing Genrix Biopharmaceutical Co Ltd (SHSE:688443) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan, Chongqing, CHN, 401338

Website

http://www.genrixbio.com

Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.

Executives

Jiang Ren Sheng

Director

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Headlines

No Headlines